208 related articles for article (PubMed ID: 22232277)
1. Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.
Xiao Y; Gerth K; Müller R; Wall D
Antimicrob Agents Chemother; 2012 Apr; 56(4):2014-21. PubMed ID: 22232277
[TBL] [Abstract][Full Text] [Related]
2. Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.
Xiao Y; Wall D
J Bacteriol; 2014 Mar; 196(6):1174-83. PubMed ID: 24391051
[TBL] [Abstract][Full Text] [Related]
3. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB
mBio; 2020 Sep; 11(5):. PubMed ID: 32900806
[TBL] [Abstract][Full Text] [Related]
4. A nonessential signal peptidase II (Lsp) of Myxococcus xanthus might be involved in biosynthesis of the polyketide antibiotic TA.
Paitan Y; Orr E; Ron EZ; Rosenberg E
J Bacteriol; 1999 Sep; 181(18):5644-51. PubMed ID: 10482504
[TBL] [Abstract][Full Text] [Related]
5. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in
Huang KJ; Pantua H; Diao J; Skippington E; Volny M; Sandoval W; Tiku V; Peng Y; Sagolla M; Yan D; Kang J; Katakam AK; Michaelian N; Reichelt M; Tan MW; Austin CD; Xu M; Hanan E; Kapadia SB
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2123117119. PubMed ID: 36099298
[No Abstract] [Full Text] [Related]
6. LspA-independent action of globomycin on Mycobacterium tuberculosis.
Banaiee N; Jacobs WR; Ernst JD
J Antimicrob Chemother; 2007 Aug; 60(2):414-6. PubMed ID: 17579235
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin.
Vogeley L; El Arnaout T; Bailey J; Stansfeld PJ; Boland C; Caffrey M
Science; 2016 Feb; 351(6275):876-80. PubMed ID: 26912896
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's Lipoprotein.
Diao J; Komura R; Sano T; Pantua H; Storek KM; Inaba H; Ogawa H; Noland CL; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Volny M; Liu P; Nickerson NN; Sandoval W; Austin CD; Murray J; Rutherford ST; Reichelt M; Xu Y; Xu M; Yanagida H; Nishikawa J; Reid PC; Cunningham CN; Kapadia SB
J Bacteriol; 2021 Jun; 203(13):e0014921. PubMed ID: 33875545
[TBL] [Abstract][Full Text] [Related]
9. The lspA gene, encoding the type II signal peptidase of Rickettsia typhi: transcriptional and functional analysis.
Rahman MS; Ceraul SM; Dreher-Lesnick SM; Beier MS; Azad AF
J Bacteriol; 2007 Jan; 189(2):336-41. PubMed ID: 17098907
[TBL] [Abstract][Full Text] [Related]
10. Bacillus licheniformis escapes from Myxococcus xanthus predation by deactivating myxovirescin A through enzymatic glucosylation.
Wang C; Liu X; Zhang P; Wang Y; Li Z; Li X; Wang R; Shang Z; Yan J; He H; Wang J; Hu W; Li Y
Environ Microbiol; 2019 Dec; 21(12):4755-4772. PubMed ID: 31600864
[TBL] [Abstract][Full Text] [Related]
11. Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin.
Olatunji S; Yu X; Bailey J; Huang CY; Zapotoczna M; Bowen K; Remškar M; Müller R; Scanlan EM; Geoghegan JA; Olieric V; Caffrey M
Nat Commun; 2020 Jan; 11(1):140. PubMed ID: 31919415
[TBL] [Abstract][Full Text] [Related]
12. Preferential selection of deletion mutations of the outer membrane lipoprotein gene of Escherichia coli by globomycin.
Zwiebel LJ; Inukai M; Nakamura K; Inouye M
J Bacteriol; 1981 Jan; 145(1):654-6. PubMed ID: 7007330
[TBL] [Abstract][Full Text] [Related]
13. Optimization of globomycin analogs as novel gram-negative antibiotics.
Garland K; Pantua H; Braun MG; Burdick DJ; Castanedo GM; Chen YC; Cheng YX; Cheong J; Daniels B; Deshmukh G; Fu Y; Gibbons P; Gloor SL; Hua R; Labadie S; Liu X; Pastor R; Stivala C; Xu M; Xu Y; Zheng H; Kapadia SB; Hanan EJ
Bioorg Med Chem Lett; 2020 Oct; 30(20):127419. PubMed ID: 32768648
[TBL] [Abstract][Full Text] [Related]
14. A NusG-like transcription anti-terminator is involved in the biosynthesis of the polyketide antibiotic TA of Myxococcus xanthus.
Paitan Y; Orr E; Ron EZ; Rosenberg E
FEMS Microbiol Lett; 1999 Jan; 170(1):221-7. PubMed ID: 9919671
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of an Escherichia coli clone overproducing prolipoprotein signal peptidase.
Tokunaga M; Loranger JM; Wu HC
J Biol Chem; 1983 Oct; 258(20):12102-5. PubMed ID: 6313636
[TBL] [Abstract][Full Text] [Related]
16. Trans-acting regulation of antibiotic TA genes in Myxococcus xanthus.
Varon M; Paitan Y; Rosenberg E
FEMS Microbiol Lett; 1997 Oct; 155(2):141-6. PubMed ID: 9351195
[TBL] [Abstract][Full Text] [Related]
17. Lethality of the covalent linkage between mislocalized major outer membrane lipoprotein and the peptidoglycan of Escherichia coli.
Yakushi T; Tajima T; Matsuyama S; Tokuda H
J Bacteriol; 1997 May; 179(9):2857-62. PubMed ID: 9139900
[TBL] [Abstract][Full Text] [Related]
18. Biogenesis of membrane lipoproteins in Escherichia coli.
Wu HC; Lai JS; Hayashi S; Giam CZ
Biophys J; 1982 Jan; 37(1):307-15. PubMed ID: 6459805
[TBL] [Abstract][Full Text] [Related]
19. The groEL2 gene, but not groEL1, is required for biosynthesis of the secondary metabolite myxovirescin in Myxococcus xanthus DK1622.
Wang Y; Li X; Zhang W; Zhou X; Li YZ
Microbiology (Reading); 2014 Mar; 160(Pt 3):488-495. PubMed ID: 24425771
[TBL] [Abstract][Full Text] [Related]
20. A distinct signal peptidase for prolipoprotein in Escherichia coli.
Tokunaga M; Loranger JM; Wu HC
J Cell Biochem; 1984; 24(2):113-20. PubMed ID: 6373799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
